Are you Dr. Riese?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 41 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
22 Chestnut Pl
Apartment 614
Brookline, MA 02445Phone+1 617-566-5516
Summary
- Dr. Richard Riese, MD is a pulmonologist in Brookline, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Brigham and Women's Faulkner Hospital.
Education & Training
Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 1995 - 1999
Brigham and Women's HospitalResidency, Internal Medicine, 1992 - 1995
Medical College of WisconsinClass of 1992
Certifications & Licensure
MA State Medical License 1994 - 2025
Clinical Trials
- Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants Start of enrollment: 2019 Dec 12
Publications & Presentations
PubMed
- 61 citationsAssociation of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO Study.Masatoshi Minamisawa, Brian Claggett, David Adams, Arnt V. Kristen, Giampaolo Merlini
JAMA Cardiology. 2019-05-01 - 37 citationsEfficacy and safety of tofacitinib in US and non-US rheumatoid arthritis patients: pooled analyses of phase II and III.Stanley Cohen, Andrew S Koenig, Lisy Wang, Kenneth Kwok, Charles A Mebus
Clinical and Experimental Rheumatology. 2016-01-01 - 237 citationsSafety and efficacy of tofacitinib, an oral janus kinase inhibitor, for the treatment of rheumatoid arthritis in open-label, longterm extension studies.Jürgen Wollenhaupt, Joel Silverfield, Eun Bong Lee, Jeffrey R. Curtis, Susan P. Wood
The Journal of Rheumatology. 2014-05-01
Press Mentions
- Synlogic Reports Third Quarter 2020 Financial Results and Provides Business UpdateNovember 5th, 2020
Synlogic Reports Second Quarter 2020 Financial Results and Provides Business UpdateAugust 6th, 2020
Synlogic Provides Summary of Impact of COVID-19 on Clinical Program Progress and Operational ActivitiesMarch 30th, 2020- Join now to see all
Grant Support
- Cathepsins In Antigen Presentation And Lung ImmunityNational Institute Of Allergy And Infectious Diseases2003–2004
- Cathepsin S In MHC Class II Antigen PresentationNational Institute Of Allergy And Infectious Diseases1999–2003
